Data Point to Promise of Stem Cell Therapies for CALD Patients, Bluebird Bio Reports
News
Bluebird Bio presented recent data from clinical trials in which two of its lead investigational therapies for cerebral adrenoleukodystrophy (CALD) were tested — a gene therapy that uses patient-derived stem ... Read more